Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOMCAT: Trans-arterial Treatment for Intra-hepatic Cholangiocarcinoma
NCT06313203Phase 2Recruiting
- Sponsor
- Oslo University Hospital
- Start
- Feb 2024
- Primary completion
- Jan 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of floxuridine in intrahepatic cholangiocarcinoma (ICC), sponsored by Oslo University Hospital. Started Feb 2024; status: recruiting.
02
Drugs
floxuridine
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT06313203.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06313203.